Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWH
851
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $12.4M | 0.02% |
287,310
-287,296
| -50% | -$12.2M |
|
852
Columbia Banking Systems
COLB
$8.67B
| $12.4M | 0.02% |
379,649
+182,040
| +92% | +$5.55M |
|
853
Avery Dennison
AVY
$13.9B
| $12.3M | 0.02% |
+202,549
| New | +$11.8M |
|
854
Green Plains
GPRE
$1.05B
| $12.3M | 0.02% |
447,976
+149,058
| +50% | +$4.59M |
|
|
RPTP
855
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $12.3M | 0.02% |
780,199
-76,519
| -9% | -$929K |
|
|
AXE
856
DELISTED
Anixter International Inc
AXE
| $12.2M | 0.02% |
187,817
+111,805
| +147% | +$7.92M |
|
|
857
CALL
Altria Group
MO
$114B
| $12.2M | 0.02% |
250,000
| – | – |
|
|
GHDX
858
DELISTED
Genomic Health, Inc.
GHDX
| $12.2M | 0.02% |
439,879
+154,522
| +54% | +$4.36M |
|
|
ABMD
859
DELISTED
Abiomed Inc
ABMD
| $12.2M | 0.02% |
185,920
+37,649
| +25% | +$2.5M |
|
|
LUMO
860
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $12.2M | 0.02% |
30,623
+27,574
| +904% | +$11.7M |
|
|
SLCA
861
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $12.2M | 0.02% |
414,900
| – | – |
|
|
MDSO
862
DELISTED
Medidata Solutions, Inc.
MDSO
| $12.1M | 0.02% |
+223,241
| New | +$12M |
|
|
GMCR
863
DELISTED
KEURIG GREEN MTN INC
GMCR
| $12.1M | 0.02% |
158,241
+131,052
| +482% | +$12.9M |
|
|
ITG
864
DELISTED
Investment Technology Group Inc
ITG
| $12.1M | 0.02% |
487,629
+22,045
| +5% | +$627K |
|
865
Pitney Bowes
PBI
$2.27B
| $12.1M | 0.02% |
579,922
-222,270
| -28% | -$5.01M |
|
866
Fidelity National Financial
FNF
$12.7B
| $12.1M | 0.02% |
469,749
-566,203
| -55% | -$14.6M |
|
|
EDE
867
DELISTED
Empire District Electric
EDE
| $12M | 0.02% |
551,598
+426,258
| +340% | +$10M |
|
868
KB Home
KBH
$3.41B
| $12M | 0.02% |
723,829
-540,722
| -43% | -$8.25M |
|
869
UGI
UGI
$8.19B
| $12M | 0.02% |
347,400
-85,138
| -20% | -$3.02M |
|
|
CTLT
870
DELISTED
CATALENT, INC.
CTLT
| $12M | 0.02% |
407,862
+207,483
| +104% | +$6.26M |
|
|
HZNP
871
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12M | 0.02% |
344,211
+35,103
| +11% | +$1.07M |
|
872
Ironwood Pharmaceuticals
IRWD
$682M
| $12M | 0.02% |
1,183,487
-1,657,376
| -58% | -$19.3M |
|
|
HI
873
DELISTED
Hillenbrand
HI
| $11.9M | 0.02% |
388,809
+62,948
| +19% | +$1.94M |
|
|
FOE
874
DELISTED
Ferro Corporation
FOE
| $11.9M | 0.02% |
710,928
+267,089
| +60% | +$3.87M |
|
|
PWE
875
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $11.9M | 0.02% |
6,890,806
+121,978
| +2% | +$252K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.